Oral Rotavirus Vaccine-North America Market Status and Trend Report 2013-2023
Report Summary
Oral Rotavirus Vaccine-North America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Oral Rotavirus Vaccine industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
North America Oral Rotavirus Vaccine Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
United States
Canada
Mexico
North America Oral Rotavirus Vaccine Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou Lamb
North America Oral Rotavirus Vaccine Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Vaccination Station
Other
North America Oral Rotavirus Vaccine Market: Players Segment Analysis (Company and Product introduction, Oral Rotavirus Vaccine Sales Volume, Revenue, Price and Gross Margin):
GSK
Sanofi-Pasteur
Merck
CSL Biotherapies
LG Life Sciences
Crucell
China National Biotec Group
Hualan Biological Engineering
Sinovac Biotech
Dalian Hissen Bio-pharm
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Oral Rotavirus Vaccine-North America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Oral Rotavirus Vaccine industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
- Whole North America and Regional Market Size of Oral Rotavirus Vaccine 2013-2017, and development forecast 2018-2023
- Main market players of Oral Rotavirus Vaccine in North America, with company and product introduction, position in the Oral Rotavirus Vaccine market
- Market status and development trend of Oral Rotavirus Vaccine by types and applications
- Cost and profit status of Oral Rotavirus Vaccine, and marketing status
- Market growth drivers and challenges
North America Oral Rotavirus Vaccine Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
United States
Canada
Mexico
North America Oral Rotavirus Vaccine Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou Lamb
North America Oral Rotavirus Vaccine Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Vaccination Station
Other
North America Oral Rotavirus Vaccine Market: Players Segment Analysis (Company and Product introduction, Oral Rotavirus Vaccine Sales Volume, Revenue, Price and Gross Margin):
GSK
Sanofi-Pasteur
Merck
CSL Biotherapies
LG Life Sciences
Crucell
China National Biotec Group
Hualan Biological Engineering
Sinovac Biotech
Dalian Hissen Bio-pharm
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF ORAL ROTAVIRUS VACCINE
1.1 Definition of Oral Rotavirus Vaccine in This Report
1.2 Commercial Types of Oral Rotavirus Vaccine
1.2.1 Rotarix
1.2.2 RotaTeq
1.2.3 Rotavac
1.2.4 Rotavin-M1
1.2.5 Lanzhou Lamb
1.3 Downstream Application of Oral Rotavirus Vaccine
1.3.1 Hospital
1.3.2 Vaccination Station
1.3.3 Other
1.4 Development History of Oral Rotavirus Vaccine
1.5 Market Status and Trend of Oral Rotavirus Vaccine 2013-2023
1.5.1 North America Oral Rotavirus Vaccine Market Status and Trend 2013-2023
1.5.2 Regional Oral Rotavirus Vaccine Market Status and Trend 2013-2023
CHAPTER 2 NORTH AMERICA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Oral Rotavirus Vaccine in North America 2013-2017
2.2 Consumption Market of Oral Rotavirus Vaccine in North America by Regions
2.2.1 Consumption Volume of Oral Rotavirus Vaccine in North America by Regions
2.2.2 Revenue of Oral Rotavirus Vaccine in North America by Regions
2.3 Market Analysis of Oral Rotavirus Vaccine in North America by Regions
2.3.1 Market Analysis of Oral Rotavirus Vaccine in United States 2013-2017
2.3.2 Market Analysis of Oral Rotavirus Vaccine in Canada 2013-2017
2.3.3 Market Analysis of Oral Rotavirus Vaccine in Mexico 2013-2017
2.4 Market Development Forecast of Oral Rotavirus Vaccine in North America 2018-2023
2.4.1 Market Development Forecast of Oral Rotavirus Vaccine in North America 2018-2023
2.4.2 Market Development Forecast of Oral Rotavirus Vaccine by Regions 2018-2023
CHAPTER 3 NORTH AMERICA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole North America Market Status by Types
3.1.1 Consumption Volume of Oral Rotavirus Vaccine in North America by Types
3.1.2 Revenue of Oral Rotavirus Vaccine in North America by Types
3.2 North America Market Status by Types in Major Countries
3.2.1 Market Status by Types in United States
3.2.2 Market Status by Types in Canada
3.2.3 Market Status by Types in Mexico
3.3 Market Forecast of Oral Rotavirus Vaccine in North America by Types
CHAPTER 4 NORTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Oral Rotavirus Vaccine in North America by Downstream Industry
4.2 Demand Volume of Oral Rotavirus Vaccine by Downstream Industry in Major Countries
4.2.1 Demand Volume of Oral Rotavirus Vaccine by Downstream Industry in United States
4.2.2 Demand Volume of Oral Rotavirus Vaccine by Downstream Industry in Canada
4.2.3 Demand Volume of Oral Rotavirus Vaccine by Downstream Industry in Mexico
4.3 Market Forecast of Oral Rotavirus Vaccine in North America by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ORAL ROTAVIRUS VACCINE
5.1 North America Economy Situation and Trend Overview
5.2 Oral Rotavirus Vaccine Downstream Industry Situation and Trend Overview
CHAPTER 6 ORAL ROTAVIRUS VACCINE MARKET COMPETITION STATUS BY MAJOR PLAYERS IN NORTH AMERICA
6.1 Sales Volume of Oral Rotavirus Vaccine in North America by Major Players
6.2 Revenue of Oral Rotavirus Vaccine in North America by Major Players
6.3 Basic Information of Oral Rotavirus Vaccine by Major Players
6.3.1 Headquarters Location and Established Time of Oral Rotavirus Vaccine Major Players
6.3.2 Employees and Revenue Level of Oral Rotavirus Vaccine Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 ORAL ROTAVIRUS VACCINE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 GSK
7.1.1 Company profile
7.1.2 Representative Oral Rotavirus Vaccine Product
7.1.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of GSK
7.2 Sanofi-Pasteur
7.2.1 Company profile
7.2.2 Representative Oral Rotavirus Vaccine Product
7.2.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of Sanofi-Pasteur
7.3 Merck
7.3.1 Company profile
7.3.2 Representative Oral Rotavirus Vaccine Product
7.3.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of Merck
7.4 CSL Biotherapies
7.4.1 Company profile
7.4.2 Representative Oral Rotavirus Vaccine Product
7.4.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of CSL Biotherapies
7.5 LG Life Sciences
7.5.1 Company profile
7.5.2 Representative Oral Rotavirus Vaccine Product
7.5.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of LG Life Sciences
7.6 Crucell
7.6.1 Company profile
7.6.2 Representative Oral Rotavirus Vaccine Product
7.6.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of Crucell
7.7 China National Biotec Group
7.7.1 Company profile
7.7.2 Representative Oral Rotavirus Vaccine Product
7.7.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of China National Biotec Group
7.8 Hualan Biological Engineering
7.8.1 Company profile
7.8.2 Representative Oral Rotavirus Vaccine Product
7.8.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of Hualan Biological Engineering
7.9 Sinovac Biotech
7.9.1 Company profile
7.9.2 Representative Oral Rotavirus Vaccine Product
7.9.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of Sinovac Biotech
7.10 Dalian Hissen Bio-pharm
7.10.1 Company profile
7.10.2 Representative Oral Rotavirus Vaccine Product
7.10.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of Dalian Hissen Bio-pharm
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ORAL ROTAVIRUS VACCINE
8.1 Industry Chain of Oral Rotavirus Vaccine
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ORAL ROTAVIRUS VACCINE
9.1 Cost Structure Analysis of Oral Rotavirus Vaccine
9.2 Raw Materials Cost Analysis of Oral Rotavirus Vaccine
9.3 Labor Cost Analysis of Oral Rotavirus Vaccine
9.4 Manufacturing Expenses Analysis of Oral Rotavirus Vaccine
CHAPTER 10 MARKETING STATUS ANALYSIS OF ORAL ROTAVIRUS VACCINE
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Oral Rotavirus Vaccine in This Report
1.2 Commercial Types of Oral Rotavirus Vaccine
1.2.1 Rotarix
1.2.2 RotaTeq
1.2.3 Rotavac
1.2.4 Rotavin-M1
1.2.5 Lanzhou Lamb
1.3 Downstream Application of Oral Rotavirus Vaccine
1.3.1 Hospital
1.3.2 Vaccination Station
1.3.3 Other
1.4 Development History of Oral Rotavirus Vaccine
1.5 Market Status and Trend of Oral Rotavirus Vaccine 2013-2023
1.5.1 North America Oral Rotavirus Vaccine Market Status and Trend 2013-2023
1.5.2 Regional Oral Rotavirus Vaccine Market Status and Trend 2013-2023
CHAPTER 2 NORTH AMERICA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Oral Rotavirus Vaccine in North America 2013-2017
2.2 Consumption Market of Oral Rotavirus Vaccine in North America by Regions
2.2.1 Consumption Volume of Oral Rotavirus Vaccine in North America by Regions
2.2.2 Revenue of Oral Rotavirus Vaccine in North America by Regions
2.3 Market Analysis of Oral Rotavirus Vaccine in North America by Regions
2.3.1 Market Analysis of Oral Rotavirus Vaccine in United States 2013-2017
2.3.2 Market Analysis of Oral Rotavirus Vaccine in Canada 2013-2017
2.3.3 Market Analysis of Oral Rotavirus Vaccine in Mexico 2013-2017
2.4 Market Development Forecast of Oral Rotavirus Vaccine in North America 2018-2023
2.4.1 Market Development Forecast of Oral Rotavirus Vaccine in North America 2018-2023
2.4.2 Market Development Forecast of Oral Rotavirus Vaccine by Regions 2018-2023
CHAPTER 3 NORTH AMERICA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole North America Market Status by Types
3.1.1 Consumption Volume of Oral Rotavirus Vaccine in North America by Types
3.1.2 Revenue of Oral Rotavirus Vaccine in North America by Types
3.2 North America Market Status by Types in Major Countries
3.2.1 Market Status by Types in United States
3.2.2 Market Status by Types in Canada
3.2.3 Market Status by Types in Mexico
3.3 Market Forecast of Oral Rotavirus Vaccine in North America by Types
CHAPTER 4 NORTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Oral Rotavirus Vaccine in North America by Downstream Industry
4.2 Demand Volume of Oral Rotavirus Vaccine by Downstream Industry in Major Countries
4.2.1 Demand Volume of Oral Rotavirus Vaccine by Downstream Industry in United States
4.2.2 Demand Volume of Oral Rotavirus Vaccine by Downstream Industry in Canada
4.2.3 Demand Volume of Oral Rotavirus Vaccine by Downstream Industry in Mexico
4.3 Market Forecast of Oral Rotavirus Vaccine in North America by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ORAL ROTAVIRUS VACCINE
5.1 North America Economy Situation and Trend Overview
5.2 Oral Rotavirus Vaccine Downstream Industry Situation and Trend Overview
CHAPTER 6 ORAL ROTAVIRUS VACCINE MARKET COMPETITION STATUS BY MAJOR PLAYERS IN NORTH AMERICA
6.1 Sales Volume of Oral Rotavirus Vaccine in North America by Major Players
6.2 Revenue of Oral Rotavirus Vaccine in North America by Major Players
6.3 Basic Information of Oral Rotavirus Vaccine by Major Players
6.3.1 Headquarters Location and Established Time of Oral Rotavirus Vaccine Major Players
6.3.2 Employees and Revenue Level of Oral Rotavirus Vaccine Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 ORAL ROTAVIRUS VACCINE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 GSK
7.1.1 Company profile
7.1.2 Representative Oral Rotavirus Vaccine Product
7.1.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of GSK
7.2 Sanofi-Pasteur
7.2.1 Company profile
7.2.2 Representative Oral Rotavirus Vaccine Product
7.2.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of Sanofi-Pasteur
7.3 Merck
7.3.1 Company profile
7.3.2 Representative Oral Rotavirus Vaccine Product
7.3.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of Merck
7.4 CSL Biotherapies
7.4.1 Company profile
7.4.2 Representative Oral Rotavirus Vaccine Product
7.4.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of CSL Biotherapies
7.5 LG Life Sciences
7.5.1 Company profile
7.5.2 Representative Oral Rotavirus Vaccine Product
7.5.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of LG Life Sciences
7.6 Crucell
7.6.1 Company profile
7.6.2 Representative Oral Rotavirus Vaccine Product
7.6.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of Crucell
7.7 China National Biotec Group
7.7.1 Company profile
7.7.2 Representative Oral Rotavirus Vaccine Product
7.7.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of China National Biotec Group
7.8 Hualan Biological Engineering
7.8.1 Company profile
7.8.2 Representative Oral Rotavirus Vaccine Product
7.8.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of Hualan Biological Engineering
7.9 Sinovac Biotech
7.9.1 Company profile
7.9.2 Representative Oral Rotavirus Vaccine Product
7.9.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of Sinovac Biotech
7.10 Dalian Hissen Bio-pharm
7.10.1 Company profile
7.10.2 Representative Oral Rotavirus Vaccine Product
7.10.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of Dalian Hissen Bio-pharm
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ORAL ROTAVIRUS VACCINE
8.1 Industry Chain of Oral Rotavirus Vaccine
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ORAL ROTAVIRUS VACCINE
9.1 Cost Structure Analysis of Oral Rotavirus Vaccine
9.2 Raw Materials Cost Analysis of Oral Rotavirus Vaccine
9.3 Labor Cost Analysis of Oral Rotavirus Vaccine
9.4 Manufacturing Expenses Analysis of Oral Rotavirus Vaccine
CHAPTER 10 MARKETING STATUS ANALYSIS OF ORAL ROTAVIRUS VACCINE
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
